Showing results (251-260 of 339) with videos related to
Sort By:
Pageof 34
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|December 30, 2009
[Risk factors of intrahepatic cholangiocarcinoma: a case-control study]Hua-bang Zhou, Qin-rong Xu, Hui Wang, et al.Journal of Hepatology|December 17, 2008
The role of microRNA expression pattern in human intrahepatic cholangiocarcinomaLei Chen, He-Xin Yan, Wen Yang, et al.Hepatobiliary Surgery and Nutrition|May 18, 2019
Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinomaZhen-Li Li, Jun Han, Kai Liu, et al.The Oncologist|May 31, 2020
Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular CarcinomaMing-Da Wang, Chao Li, Lei Liang, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 16, 2019
A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: A large-scale, multicenter studyXiu-Ping Zhang, Zhen-Hua Chen, Teng-Fei Zhou, et al.The Journal of Experimental Medicine|October 24, 2007
LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophagesXiao-Ni Kong, He-Xin Yan, Lei Chen, et al.World Journal of Surgery|November 22, 2013
Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasionHan Zhang, Shou-Xin Yuan, Shu-Yang Dai, et al.Hepatology (Baltimore, Md.)|August 3, 2011
Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in miceLiang Li, Lei Chen, Liang Hu, et al.Cancer Letters|August 8, 2009
Autophagic cell death induced by 5-FU in Bax or PUMA deficient human colon cancer cellHai-yan Xiong, Xian-ling Guo, Xin-xin Bu, et al.Acta Pharmacologica Sinica|May 4, 2022
Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cellsHao Shen, Han Yu, Qian-Yu Li, et al.Pageof 34